Why Glenmark Pharma's New Cancer Deal with AbbVie is a Big Deal for Investors
Glenmark Pharmaceuticals saw its share price climb 10% after one of its divisions signed a special agreement with the American company AbbVie to work ...
Back to All News
ABBV
Latest ABBV News
Stay updated with the latest market insights and press releases for ABBV